These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9790085)
41. Importance of uniform heparin coating on biopolymers. Da Luz Moreira P; Wada ML; Novello WP Artif Organs; 2000 Mar; 24(3):209-11. PubMed ID: 10759643 [TBL] [Abstract][Full Text] [Related]
42. Prolonged extracorporeal respiration with a membrane gas exchanger. Awad JA; Matte J; Brassard A J Thorac Cardiovasc Surg; 1973 Jul; 66(1):40-51. PubMed ID: 4715384 [No Abstract] [Full Text] [Related]
43. The effects of pre-arrest heparin administration dose for cardiac arrest model using extracorporeal lung and a heart assist (ECLHA) in dogs. Ichinose K; Okamoto T; Tashiro M; Tanimoto H; Terasaki H Resuscitation; 2006 May; 69(2):311-8. PubMed ID: 16460866 [TBL] [Abstract][Full Text] [Related]
44. Newborn extracorporeal lung assist using a novel double lumen catheter and a heparin-bonded membrane lung. Tsuno K; Terasaki H; Otsu T; Okamoto T; Sakanashi Y; Morioka T Intensive Care Med; 1993; 19(2):70-2. PubMed ID: 8486871 [TBL] [Abstract][Full Text] [Related]
45. Five-day partial bypass using a membrane oxygenator without systemic heparinzation. Hagler HK; Powell WM; Eberle JW; Sugg WL; Platt MR; Watson JT Trans Am Soc Artif Intern Organs; 1975; 21():178-87. PubMed ID: 238328 [TBL] [Abstract][Full Text] [Related]
46. An in vitro comparison of gas transfer and pressure drop of the Bentley Duraflo Coated Spiral Gold and the Medtronic Carmeda Coated Maxima hollow fiber membrane oxygenators. Vocelka CR; Thomas R; Verrier E; Kunzelman K J Extra Corpor Technol; 1997 Dec; 29(4):185-8. PubMed ID: 10176127 [TBL] [Abstract][Full Text] [Related]
47. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices. Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323 [TBL] [Abstract][Full Text] [Related]
48. Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation. Urlesberger B; Zobel G; Rödl S; Dacar D; Friehs I; Leschnik B; Muntean W Int J Artif Organs; 1997 Dec; 20(12):708-12. PubMed ID: 9506788 [TBL] [Abstract][Full Text] [Related]
49. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis. Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142 [TBL] [Abstract][Full Text] [Related]
50. Twenty-four hour membrane oxygenation in dogs without anticoagulation. Fletcher JR; McKee AE; Mills M; Snyder KC; Herman CM Surgery; 1976 Aug; 80(2):214-23. PubMed ID: 941094 [TBL] [Abstract][Full Text] [Related]
51. Nature of thrombus in a hollow fiber oxygenator. Schneider MD Am J Vet Res; 1973 Feb; 34(2):151-68. PubMed ID: 4568247 [No Abstract] [Full Text] [Related]
52. Veno-right ventricular bypass as total extracorporeal lung assistance. An experimental study. Koul B; Wetterberg T; Sjöberg T; Kimblad PO; Kugelberg J; Steen S J Thorac Cardiovasc Surg; 1991 Apr; 101(4):719-23. PubMed ID: 1901124 [TBL] [Abstract][Full Text] [Related]
53. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose. Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424 [TBL] [Abstract][Full Text] [Related]
54. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305 [TBL] [Abstract][Full Text] [Related]
55. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of heparin-coated circuits with full heparin dose strategy. Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761 [TBL] [Abstract][Full Text] [Related]
57. Improvement in hemocompatibility of chitosan/soy protein composite membranes by heparinization. Wang X; Shi N; Chen Y; Li C; Du X; Jin W; Chen Y; Chang PR Biomed Mater Eng; 2012; 22(1-3):143-50. PubMed ID: 22766713 [TBL] [Abstract][Full Text] [Related]
58. A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit. Palatianos GM; Foroulis CN; Vassili MI; Astras G; Triantafillou K; Papadakis E; Lidoriki AA; Iliopoulou E; Melissari EN Ann Thorac Surg; 2003 Jul; 76(1):129-35. PubMed ID: 12842526 [TBL] [Abstract][Full Text] [Related]
59. Cytokine generation in rabbits during extracorporeal lung assist with a mini hollow fiber lung. Yanagi F; Terasaki H; Matsukawa A; Ohkawara S; Morioka T; Yoshinaga M Artif Organs; 1996 Mar; 20(3):209-17. PubMed ID: 8694691 [TBL] [Abstract][Full Text] [Related]
60. Reduction of platelet trapping in membrane oxygenators by transmembraneous application of gaseous nitric oxide. Keh D; Gerlach M; Kürer I; Falke KJ; Gerlach H Int J Artif Organs; 1996 May; 19(5):291-3. PubMed ID: 8791149 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]